Podcast Summary: "Stem Cells, Exosomes & the Future of Recovery"

Coffeez for Closers with Joe Shalaby
Host: Joseph Shalaby
Guest: Seth Bergey
Date: January 30, 2026

Episode Overview

This episode explores the world of regenerative medicine, focusing on stem cells, exosomes, and the evolving industry landscape. Host Joe Shalaby interviews Seth Bergey—one of the largest distributors of stem cells in America—about how he entered the field, the mechanics of stem cell therapy, regulatory challenges, business strategy, misconceptions, and the burgeoning overlap with biohacking, med spas, and beauty treatments. The conversation also touches on the personal motivations fueling Seth’s work and what lies ahead for the field of cellular repair.

Key Discussion Points & Insights

The Reality and Accessibility of Stem Cell Therapy

• Misconceptions: Many believe stem cell therapy is unattainable, exclusive, and prohibitively expensive or only available overseas, e.g., Panama.
  • "So many people still think stem cells therapy is unattainable...it's not cheap." – Seth (00:00)
• Direct-to-Consumer Model: Seth’s business model sidesteps the traditional brick-and-mortar clinics by employing mobile nurse practitioners for in-home treatments.
  • "Now I have almost 100 nurse practitioners, doctors, and I'm in all 50 states. And we can send our medical team directly to somebody and anywhere in the country virtually to get the treatment done." — Seth (09:53)

Seth's Entry into Stem Cells & Regenerative Revival’s Vision

• Origin Story: Originally a serial entrepreneur, Seth entered the stem cell space not out of initial passion for the science, but as an opportunity for innovative, meaningful business.
  • “I first looked at it from the business opportunity, not even necessarily the health and wellness space...But this is actually fun and rewarding, you know, getting to see lives change.” — Seth (02:01)
• Educational Approach: Using dinner seminars to demystify the technology for the public and drive business by focusing on relatable, solution-oriented messaging rather than scientific jargon.
  • “The problem isn’t the science, it’s communicating the science.” — Seth (07:35)

Industry Growth, Regulatory Gray Areas, and Challenges

• Explosive Market Growth: Stem cell and exosome therapy is estimated to be a $10B industry, projected to reach $40–$50B by 2030.
  • “...expected, at least by 2030, expected to be 40 to $50 billion industry, if not more.” — Seth (04:53)
• Regulatory Environment:
  • The FDA regulates the labs/process, but stem cell products (biologics) are not FDA-approved drugs, creating a "gray area"
  • FTC and FDA scrutinize marketing claims strictly—statements must remain conservative and supported, no guarantees
    • "You have to be very, very careful. I've seen a lot of people in this space say the wrong things, try to cut corners...making unfounded claims." — Seth (11:00)
  • Insurance will not cover stem cell therapy at present; big pharma resistance noted as a substantial barrier
    • “A patient cured is a customer lost.” — Seth (15:08)

What Stem Cells & Exosomes Really Are

• Definitions and Metaphors:
  • Exosomes: “The exosomes are like the blueprint. If you can get stem cells and exosomes working together, that's going to be your best bet.” — Seth (20:16)
  • Sourcing: All products come from screened birthing tissue (umbilical cord, placenta, amniotic fluid); US law restricts “manipulation”/expansion of stem cells, which distinguishes US treatments from overseas clinics.
    • "Those 80 million cells...that we ran through, that's 80 million original, undifferentiated, uncultured." — Seth (31:06)

Application, Use Cases, and Consumer Experience

• Injury and Recovery: Used primarily for chronic pain (e.g., knee, shoulder), injury recovery, autoimmune and inflammatory issues, and now for cosmetic and aesthetic uses.
  • “One of the most common things we hear...is ‘I’m out of pain. Almost completely out of pain. And surgery is now off the table.’” — Seth (24:25)
• Safety and Recovery:
  • Most treatments are minimally invasive (IV or joint injection). Rapid, often painless recovery:
    • "There was no recovery time. And they're like, yeah, you just went through a procedure. I'm like, that was a procedure?" — Joseph (21:20)
  • Collaboration is growing across the industry to strengthen best practices, data, and patient outcomes.
    • "Collaboration, not competition, is one of the things we say in that group." — Seth (26:04)

Cosmetic and Aesthetic Applications

• Vampire Facelifts, PRP vs. Wharton’s Jelly:
  • Wharton’s Jelly is the stem-cell rich substance from umbilical cords; it contains stem cells, exosomes, collagens, hyaluronic acid, and growth factors.
  • Used for facials ("vampire facelifts"), under-eye lifts, and hair restoration; exosomes and stem cells have rapidly replaced older PRP (platelet-rich plasma) techniques for cosmetic procedures.
    • "Wharton’s Jelly is this gooey good stuff...the richest source in all of earth for stem cells, for collagens..." — Seth (34:26)

Overcoming Skepticism and Industry Hurdles

• Educating Reluctant Patients:
  • “If somebody goes and asks their traditional doctor who makes their house payment, their car payment by...doing cortisone shots and knee surgeries, it’s pretty hard to get them on your side regarding something new like stem cell therapy.” — Seth (21:55)
• Professional Buy-In: The majority of collaborating doctors are from private practice—hospitals remain more bureaucratic and risk-averse.

The Future of Regenerative Medicine & AI

• Regulation and Standardization: Expect more compliance and clear rules, which will flush out bad actors and improve legitimacy; welcomed by Seth and other responsible industry leaders.
  • "There needs to be some regulation in the healthcare space. So what I'm seeing is there's going to be some more uniformity." — Seth (17:28)
• Biohacking & AI:
  • Increasing intersection with AI for demographic targeting in marketing; rapid progress expected to lead to capabilities such as lab-grown organs.
  • “They’re going to be able to use stem cells to like recreate entire organs. You know, like you’ll be able to...take some of your own stem cells, give us a month in the lab, we’ll grow you a new one. That’s honestly the future of stem cell therapy.” — Seth (26:42)

Access and How to Get Treated

• Direct Message Approach:
  • Most people now access stem cell therapy by contacting specialized providers directly—med spas are increasingly adopting stem cell treatments, but not universally.
    • “For every 10 med spas, probably only two of them are offering it for now.” — Seth (38:15)
  • Seth and his company offer both patient treatments and consulting for practitioners/med spa owners looking to enter the space.

Notable Quotes & Memorable Moments

• On Business and Personal Impact:
  • "Business is a sport. Right?...My main sport is business." — Seth (40:10)
• On Interference by Big Pharma:
  • "A patient cured is a customer lost." — Seth (15:08)
• On U.S. vs Overseas Treatments:
  • "So the only reason you need to go to Panama or overseas would be...something crazy...But if you’re talking about the run of the mill...All that stuff can be done right here in the States for a fraction of the cost." — Seth (29:01)
• On Passion for Helping Others:
  • "I hope I hear that I had a positive impact on everybody that I was around." — Seth (44:34)

Noteworthy Segments & Timestamps

• Stem Cell Myths vs. Reality / Panama Myths:
  • 00:00–02:00; 28:49–31:14
• Seth’s Entrepreneurial Journey & Business Model:
  • 02:01–10:47
• Regulations, FDA, and the Industry’s Gray Area:
  • 11:00–14:25
• Professional Challenges: Recruitment, Training, & Compliance:
  • 10:47–13:43
• Industry Growth, Collaboration & Competition:
  • 18:46–20:14; 24:49–26:08
• Stem Cells & Exosomes Explained Simply:
  • 20:16–21:42
• Aesthetic/Beauty Applications & Wharton’s Jelly:
  • 33:11–36:56
• Future Advancements—Organs, Alzheimer’s, AI:
  • 26:34–29:36; 34:07
• Patient Experience & Longevity Use Cases:
  • 24:25; 31:14–33:06
• Personal, Family, and Business Goals:
  • 39:42–44:34

How to Connect & Final Thoughts

For patients and professionals interested in stem cell treatments:

• Visit RegenerativeRevival.com
• Instagram: @sethdberge and @regenerativerevival
• Consulting and product support for medical spas and practitioners available through Seth’s companies.

Closing Note:
The episode underscores the mission to make regenerative medicine accessible, transparent, and safe—leveraging education, collaboration, and responsible innovation to lead the next evolution in recovery and cellular health.